Skip to main content

Delayed Onset Muscle Soreness

0
Pipeline Programs
2
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Lead Pharma
Lead PharmaNetherlands - Oss
1 program
Loxoprofen Pain PatchPHASE_2
Cardinal Health
Cardinal HealthDUBLIN, OH
1 program
Loxoprofen Pain PatchPHASE_21 trial
Active Trials
NCT02602353Completed42Est. Dec 2015

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Cardinal HealthLoxoprofen Pain Patch

Clinical Trials (1)

Total enrollment: 42 patients across 1 trials

NCT02602353Cardinal HealthLoxoprofen Pain Patch

Pilot Study Comparing the Efficacy and Safety of a New Pain Patch and Placebo in Delayed Onset Muscle Soreness (DOMS)

Start: Oct 2015Est. completion: Dec 201542 patients
Phase 2Completed

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.